Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Luo, Weiren ^a,b   Li, Siyi ^a   Peng, Bailu ^b   Ye, Yanfen ^b   Deng, Xubin ^b   Yao, Kaitai ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX2; UVOMORULIN;

ADOLESCENT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; EMBRYONIC STEM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE CHARACTERIZATION;

ADOLESCENT; ADULT; AGED; CADHERINS; EMBRYONIC STEM CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NERVE TISSUE PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; PROTEIN TRANSPORT; SOXB1 TRANSCRIPTION FACTORS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84873741701     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056324     Document Type: Article

References (50)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Mei YP, Zhou JM, Wang Y, Huang H, Deng R, et al. (2007) Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle 6: 1379-1385.
3. Wang P, Zou H, Ding L, Chen Q, Zheng Y, et al. (2010) Association of regulatory region of HLA-DPB1 with nasopharyngeal carcinoma in southern Chinese Hans. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24: 261-263 Chinese.
4. Li X, Fasano R, Wang E, Yao KT, Marincola FM, (2009) HLA associations with nasopharyngeal carcinoma. Curr Mol Med 9: 751-765.
5. Wei WI, Sham JS, (2005) Nasopharyngeal carcinoma. Lancet 365: 2041-2054.
6. Clevers H, (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17: 313-319.
7. Dick JE, (2008) Stem cell concepts renew cancer research. Blood 112: 4793-4807.
8. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
9. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, et al. (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126-140.
10. Pesce M, Schöler HR, (2001) Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19: 271-278.
11. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, et al. (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
12. Wiese C, Rolletschek A, Kania G, Blyszczuk P, Tarasov KV, et al. (2010) Nestin expression-a property of multi-lineage progenitor cells? Cell Mol Life Sci 61: 2510-2522.
13. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, et al. (2012) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31: 1354-1365.
14. Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, et al. (2012) Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 31: 4898-4911.
15. Jeter CR, Liu B, Liu X, Chen X, Liu C, et al. (2011) NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30: 3833-3845.
16. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, et al. (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70: 10433-10444.
17. Sholl LM, Barletta JA, Yeap BY, Chirieac LR, Hornick JL, (2010) Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol 34: 1193-1198.
18. Guo Y, Liu S, Wang P, Zhao S, Wang F, et al. (2011) Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology 59: 763-775.
19. Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, et al. (2009) Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol 16: 3488-3498.
20. Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H, et al. (2012) Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma. J Surg Res 174: 130-135.
21. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, et al. (2008) Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095.
22. Zhang Y, Peng J, Zhang H, Zhu Y, Wan L, et al. (2010) Notch1 signaling is activated in cells expressing embryonic stem cell proteins in human primary nasopharyngeal carcinoma. J Otolaryngol Head Neck Surg 39: 157-166.
23. Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, et al. (2010) Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 6: e1000940.
24. Lim J, Thiery JP, (2012) Epithelial-mesenchymal transitions: insights from development. Development 139: 3471-3486.
25. Scheel C, Weinberg RA, (2011) Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int J Cancer 129: 2310-2314.
26. Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, et al. (2004) N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 10: 4125-4133.
27. Werling AM, Doerflinger Y, Brandner JM, Fuchs F, Becker JC, et al. (2011) Homo- and heterotypic cell-cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switching. Histopathology 58: 286-303.
28. Polyak K, Weinberg RA, (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009 9: 265-273.
29. Sarkar D, Shields B, Davies ML, Müller J, Wakeman JA, (2012) BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells. Int J Cancer 130: 328-337.
30. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
31. Luo W, Fang W, Li S, Yao K, (2012) Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma. Int J Cancer 131: 1863-1873.
32. Luo WR, Wu AB, Fang WY, Li SY, Yao KT, (2012) Nuclear expression of N-cadherin correlates with poor prognosis of nasopharyngeal carcinoma. Histopathology 61: 237-246.
33. Luo W, Li S, Cai L, Yao K, (2012) High Expression of Nuclear Snail, but not Cytoplasmic Staining, Predicts Poor Survival in Nasopharyngeal Carcinoma. Ann Surg Oncol 19: 2971-2979.
34. Ferletta M, Caglayan D, Mokvist L, Jiang Y, Kastemar M, et al. (2011) Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells. Int J Cancer 129: 45-60.
35. Li C, Yan Y, Ji W, Bao L, Qian H, et al. (2012) OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma. PLoS One 7: e49693.
36. Han J, Zhang F, Yu M, Zhao P, Ji W, et al. (2012) RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells. Cancer Lett 321: 80-88.
37. Yin X, Li YW, Zhang BH, Ren ZG, Qiu SJ, et al. (2012) Coexpression of stemness factors Oct4 and Nanog predict liver resection. Ann Surg Oncol 2012 19: 2877-2887.
38. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, et al. (2006) The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38: 431-440.
39. Han X, Fang X, Lou X, Hua D, Ding W, et al. (2012) Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One 7: e41335.
40. Hu J, Guo H, Li H, Liu Y, Liu J, et al. (2012) MiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4. PLoS One 7: e45965.
41. Luo WR, Chen XY, Li SY, Wu AB, Yao KT, (2012) Neoplastic spindle cells in nasopharyngeal carcinoma show features of epithelial-mesenchymal transition. Histopathology 61: 113-122.
42. Moore KA, Lemischka IR, (2006) Stem cells and their niches. Science 311: 1880-1885.
43. Lee C, Hu J, Ralls S, Kitamura T, Loh YP, et al. (2012) The molecular profiles of neural stem cell niche in the adult subventricular zone. PLoS One 7: e50501.
44. Sneddon JB, Werb Z, (2007) Location, location, location: the cancer stem cell niche. Cell Stem Cell 1: 607-611.
45. Cabarcas SM, Mathews LA, Farrar WL, (2011) The cancer stem cell niche-there goes the neighborhood? Int J Cancer 129: 2315-2327.
46. Li J, (2012) Myelodysplastic syndrome hematopoietic stem cell. Int J Cancer doi:10.1002/ijc.27896.
47. Gilbertson RJ, Rich JN, (2007) Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7: 733-736.
48. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, et al. (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82.
49. Suzuki S, Namiki J, Shibata S, Mastuzaki Y, Okano H, (2010) The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature. J Histochem Cytochem 58: 721-730.
50. He H, Li MW, Niu CS, (2012) The pathological characteristics of glioma stem cell niches. J Clin Neurosci 19: 121-127.